InVera Medical has received CE-mark approval for the company’s InVera infusion device, which has been designed to help physicians treat varicose veins and other forms of chronic venous disease more effectively.
InVera Medical notes in a press release that, unlike many existing technologies that burn the vein, the InVera device uses a non-thermal approach. The procedure is carried out in a doctor’s office, requires only a single injection of local anaesthetic, and does not need specialised hospital equipment. “This represents a major step forward in expanding non-thermal options for physicians in the management of chronic venous disease,” the company states. The device uses a thin catheter inserted into the vein under ultrasound guidance.
Stephen Cox, CEO and co-founder of InVera Medical, said: “Securing CE mark is a major milestone for InVera Medical and a significant step towards making this technology available to patients across Europe. Our focus has been on developing a less-invasive, effective non-thermal approach that fits easily into existing clinical practice while improving the treatment experience for both physicians and patients.”
InVera advises that its infusion device is not currently available in the USA or any other international markets.
